NRx submits 70,000-patient ketamine data to US FDA
NRx Pharmaceuticals (Nasdaq: NRXP) will submit real-world evidence from over 70,000 patients treated with intravenous ketamine…
Stratifying cardiovascular benefits from GLP-1RA: a multisource analysis of patient-level CVOT and real-world data using AI-driven methods | Cardiovascular Diabetology
Study design We collected individual patient-level data from the LEADER [7] and SUSTAIN-6 [8] CVOTs as well as…